Skip to main content

Minimally Invasive Surgical Instruments Market | Rapid Advancements In New Technologies To Boost The Market

A minimally invasive surgical (MIS) procedure refers to the surgery performed with minute incisions in the body; for instance, plaque blockages in the arteries of the heart and other vessel walls of peripheral organs, such as lower extremities, neck, kidneys, and brain. The principal advantage of these procedures over surgery is short recovery time, small scars, low risk of infection, less bleeding, and shorter hospital stays.

The MIS market is expected to grow at a fast rate with a CAGR of 8.2% and is expected to reach $35.5 billion. The surgical instruments segment commanded the larger share; i.e. 38.4%, of the global minimally invasive surgical devices market. This growth has been primarily attributed to the increased usage of these devices and instruments in MIS procedures. Devices such as guiding catheters and guidewires as well as balloons have been widely used in interventional angioplasty and peripheral extremity MIS procedures. Numerous innovations in the technologies of devices such as balloons have added to the growth in the market.


The global minimally invasive surgical devices market is classified into handheld instruments, guiding devices, inflation systems, auxiliary devices, ultrasound, X-ray, CT & MRI imaging, visualization systems, electrosurgical devices and robotic systems. Newer innovations and rapidly evolving technologies in the field of surgical devices used in minimally invasive procedures will drive the MIS market. Imaging and diagnostic technologies such as ultrasound involving IVUS (intravascular ultrasound) and OCT (optical coherence tomography) have considerably changed the usage patterns of diagnostic techniques. These device systems show significant promise in terms of guidance in treatment and diagnosis. OCT has helped in high-resolution imaging of atherosclerotic plaque erosions that were previously not possible with imaging systems, thereby contributing to a boosting growth to the market.

North America constitutes the biggest market for the MIS devices and technologies, followed by Europe, and Asia. Pricing and reimbursement issues in certain regions of the world such as European and Asian countries have hampered the growth of the MIS devices market. Budgets constraints in hospitals force physicians to re-use accessory devices in MIS procedures, due to lack of reimbursements.

Major players in the minimally invasive surgery devices and imaging & visualization systems market include Intuitive Surgical (U.S.), GE Healthcare (U.K.), Philips (The Netherlands), Siemens (Germany) and Covidien (U.S.).

The various devices used in MIS procedures are categorized into:
  • Surgical Devices – Handheld instruments, mechanical cutters, auxiliary devices, guiding devices (guidewires and guiding catheters) and inflation systems (balloons and balloon inflation devices)
  • Electrosurgical Devices – Electrosurgical generators, vessel sealing instruments, electrocautery devices and accessories
  • Imaging Devices – Ultrasound, CT, MRI, X-ray devices and visualization systems
  • Robotic Systems – da-Vinci, ROBODOC, RIO, Neuromate and SpineAssist
This minimally invasive surgical devices and imaging systems report forecasts the size of the market over a period of five years (2011-2016). It also discusses the key market drivers, restraints and opportunities of the market and its sub markets. The report’s ‘Strategy’ section sketches the competitive landscape, featuring about 32 company profiles.


Article Credit: Healthcare DC

Comments

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...